Insights

Expanding Market Reach Massive Bio operates across 17 countries in North America, Europe, and LATAM, demonstrating a strong international presence and potential for expansion partnerships or SaaS solutions tailored for diverse healthcare markets.

AI-Driven Innovation The company's proprietary AI technology for matching patients to clinical trials presents opportunities to offer advanced analytics tools or integrations with other health tech platforms to enhance trial matching accuracy.

Strategic Industry Engagement Massive Bio's collaborations with pharmaceutical giants like Flatiron Health and Prognos Health indicate openness to strategic integrations and joint ventures, making them a prime target for partner or technology enabling solutions.

High Growth Potential With revenue estimated between $10M and $50M and a small but expanding staff, Massive Bio is positioned for growth and scalable solutions, particularly in AI, real-world data, and patient engagement tools to support their clinical trial ecosystem.

Recognition and Credibility Recent awards and participation in prominent initiatives like the White House Cancer Moonshot boost the company's credibility, offering opportunities for premium solutions, customized consulting, or sponsored innovations to enhance their strategic initiatives.

Similar companies to Massive Bio

Massive Bio Tech Stack

Massive Bio uses 8 technology products and services including Adjust, Shopify, Font Awesome, and more. Explore Massive Bio's tech stack below.

Adjust
Analytics
Shopify
E-commerce
Font Awesome
Font Scripts
Priority Hints
Performance
Ahrefs
Search Marketing
HSTS
Security
Cloudflare Bot Management
Security
reCAPTCHA
Security

Media & News

Massive Bio's Email Address Formats

Massive Bio uses at least 1 format(s):

Massive Bio Email Formats	Example	Percentage
FLast@massivebio.com	JDoe@massivebio.com	44%
Last@massivebio.com	Doe@massivebio.com	10%
FirstL@massivebio.com	JohnD@massivebio.com	2%
FLast@massivebio.com	JDoe@massivebio.com	44%

Frequently Asked Questions

Where is Massive Bio's headquarters located?

Massive Bio's main headquarters is located at Istanbul, TR. The company has employees across 5 continents, including AsiaNorth AmericaEurope.

What is Massive Bio's phone number?

You can contact Massive Bio's main corporate office by phone at

+1-917-336-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Massive Bio's official website and social media links?

Massive Bio's official website is massivebio.com and has social profiles on LinkedIn.

How much revenue does Massive Bio generate?

As of September 2025, Massive Bio's annual revenue reached $15M.

What is Massive Bio's NAICS code?

Massive Bio's NAICS code is 62 - Health Care and Social Assistance.

How many employees does Massive Bio have currently?

As of September 2025, Massive Bio has approximately 103 employees across 5 continents, including AsiaNorth AmericaEurope. Key team members include Chief Operating Officer: S. M.Chief Financial Officer: T. O.Chief Customer Delivery Manager: S. T.. Explore Massive Bio's employee directory with LeadIQ.

What industry does Massive Bio belong to?

Massive Bio operates in the Hospitals and Health Care industry.

What technology does Massive Bio use?

Massive Bio's tech stack includes AdjustShopifyFont AwesomePriority HintsAhrefsHSTSCloudflare Bot ManagementreCAPTCHA.

What is Massive Bio's email format?

Massive Bio's email format typically follows the pattern of . Find more Massive Bio email formats with LeadIQ.

When was Massive Bio founded?

Massive Bio was founded in 2014.

Massive Bio

Hospitals and Health CareIstanbul, Turkey51-200 Employees

Massive Bio is a health-tech company transforming how cancer patients access clinical trials.

Operating in 17 countries across North America, Europe, and LATAM, we use proprietary AI technology to match patients to the most appropriate clinical trials—regardless of location, income, or cancer type.

We partner with pharmaceutical companies, CROs, and healthcare institutions to accelerate oncology trial enrollment, reduce dropout rates, and deliver real-world evidence.

💠 160K+ patients onboarded
💠 45+ pharma and CRO customers
💠 130+ strategic partners
💠 Founding member of CancerX & participant in the White House Cancer Moonshot

Explore how we simplify trial access and optimize recruitment across the oncology ecosystem.

🔗 Learn more: www.massivebio.com